home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

A Deleterious Mutation in SAMD9 Causes Normophosphatemic Familial Tumoral Calcinosis

 
  September, 13 2006 10:34
your information resource in human molecular genetics
 
     
A Deleterious Mutation in SAMD9 Causes Normophosphatemic Familial Tumoral Calcinosis

Journal:
American Journal of Human Genetics, 79:759-764, 2006.
Authors:

Orit Topaz, Margarita Indelman, Ilana Chefetz, Dan Geiger, Aryeh Metzker, Yoram Altschuler, Mordechai Choder, Dani Bercovich, Jouni Uitto, Reuven Bergman, Gabriele Richard, and Eli Sprecher

From the Department of Dermatology and Laboratory of Molecular Dermatology, Rambam Health Care Campus (O.T.; M.I.; I.C.; R.B.; E.S.), and Faculty of Medicine (O.T.; I.C.; M.C.; R.B.; E.S.), Computer Sciences Department (D.G.), and Rappaport Institute for Research in the Medical Sciences, Technion (E.S.), Israel Institute of Technology, Haifa; Department of Dermatology, Souraski Medical Center, Tel Aviv (A.M.); Department of Pharmacology, School of Pharmacy, Hebrew University, Jerusalem (Y.A.); Human Molecular Genetics & Pharmacogenetics, Migal-Galilee Technology Center, Kiryat-Shmona, Israel (D.B.); Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia (J.U.; G.R.); and GeneDx, Gaithersburg, MD (G.R.)

Abstract

Familial tumoral calcinosis (FTC) is a rare autosomal recessive disorder characterized by the progressive deposition of calcified masses in cutaneous and subcutaneous tissues, which results in painful ulcerative lesions and severe skin and bone infections. Two major types of FTC have been recognized: hyperphosphatemic FTC (HFTC) and normophosphatemic FTC (NFTC)…….more…..

(C) American Journal of Human Genetics.

Posted by: Tressie Dalaya


Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.